Rapid communication
Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca2+/calmodulin-dependent protein kinase II

https://doi.org/10.1016/S0014-2999(03)01484-5Get rights and content

Abstract

It has been reported that Ca2+/calmodulin-dependent protein kinase II (CaMKII) can modulate opioid tolerance via its action on learning and memory. In this study, we examine if CaMKII can directly affect opioid tolerance. We found that spinal CaMKII activity was increased in rats tolerant to morphine. In these rats, acute spinal administration of 2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine) (KN93), a CaMKII inhibitor, was able to reverse the already-established antinociceptive tolerance. These results suggest that CaMKII may directly promote opioid tolerance.

Section snippets

Acknowledgments

This work was supported in part by a grant from the NIH (DA05050) and funds from the University of Illinois.

References (8)

  • I. Bruggemann et al.

    Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct pain-processing brain regions

    Brain. Res. Mol. Brain Res.

    (2000)
  • G.H. Fan et al.

    Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence

    Mol. Pharmacol.

    (1999)
  • T. Koch et al.

    Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization

    J. Neurochem.

    (1997)
  • L. Lou et al.

    Modulation of Ca2+/calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of alpha and beta isoforms

    Mol. Pharmacol.

    (1999)
There are more references available in the full text version of this article.

Cited by (0)

View full text